State of the science for myelodysplastic syndrome: prognosis and promise of new therapies.
Rowe
Jacob M
JM
Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa 31096, Israel.
D000970:Antineoplastic Agents / Q000145:classification / Q000494:pharmacology* / Q000627:therapeutic use; D016503:Drug Delivery Systems; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D011379:Prognosis
D000970:Antineoplastic Agents